KRAS Mutation-Related Tumors

Explore clinical trials studying KRAS Mutation-Related Tumors. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

KRAS Mutation-Related Tumors trial results

Recruiting

NCT07064018

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +38 more
Locations: Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States

Recruiting

NCT05786924

Conditions: Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations: Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States

The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California, San Francisco (UCSF) San Francisco, California, United States

View all 27 locations

Recruiting

NCT05661201

Conditions: KRAS Mutation-Related Tumors, Solid Tumor
Locations: Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

Not Yet Recruiting

NCT06456138

Conditions: Advanced Lung Cancer, KRAS Mutation-Related Tumors, Neoplasms, +1 more
Locations: Shanghai Chest Hospital Shanghai, China

Completed

NCT03597581

Conditions: CRC, Colonic Diseases, Colorectal Cancer, +18 more
Locations: Arizona Oncology Associates, PC - HAL Prescott Valley, Arizona, United States

Arizona Oncology Associates, PC - HOP E Tucson, Arizona, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Sharp HealthCare San Diego, California, United States

View all 17 locations

Completed

NCT04735068

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States